ALTG Trials
The following ALTG trials are listed on the Australian and New Zealand Clinical Trials Registry website:
| Trial Number |
Title |
ACTR Number |
| ALTG 04/003 |
MATES: Maintenance Thalidomide in Mesothelioma Patients. A phase III trial of anti-angiogenic agent Thalidomide in patients with malignant pleural mesothelioma after first line chemotherapy. |
ACTRN12609000141246 |
| ALTG 04/008 |
ANTS Trial (Australian Neoadjuvant Therapy Study for Non-small Cell Lung Cancer). A randomised phase II study comparing cisplatin and docetaxel with or without cetuximab given as neoadjuvant therapy in patients with stage II and IIIA resectable non-small cell lung cancer.
|
ACTRN12608000061336 |
| ALTG 06/003 |
NITRO: A Phase III, randomised trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer |
ACTRN12608000588392 |
| ALTG 09/001 |
BR.29. A double blind randomised trial of cediranib versus placebo in patients receiving paclitaxel/carboplatin chemotherapy for the treatment of advanced or metastatic non-small cell lung cancer. |
ACTRN12609000247279 |
|
|
Last Updated ( Thursday, 30 July 2009 )
|
